메뉴 건너뛰기




Volumn 34, Issue SUPPL. 1, 2013, Pages

Onabotulinum toxin A for treatment of chronic migraine with medication overuse

Author keywords

Chronic migraine; Medication overuse; Onabotulinum toxin A

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT; NARCOTIC ANALGESIC AGENT;

EID: 84892503773     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-013-1381-1     Document Type: Article
Times cited : (7)

References (11)
  • 1
    • 3142528289 scopus 로고    scopus 로고
    • Medication-overuse headache: A worldwide problem
    • Diener HC, Limmroth V (2004) Medication-overuse headache: a worldwide problem. Lancet Neurol 3:475-483
    • (2004) Lancet Neurol , vol.3 , pp. 475-483
    • Diener, H.C.1    Limmroth, V.2
  • 2
    • 65549170385 scopus 로고    scopus 로고
    • Treatment of chronic migraine with medication overuse: Is drug withdrawal crucial?
    • Grazzi L, Andrasik F, Usai S, Bussone G (2009) Treatment of chronic migraine with medication overuse: is drug withdrawal crucial? Neurol Sci 30(S1):85-88
    • (2009) Neurol Sci , vol.30 , Issue.S1 , pp. 85-88
    • Grazzi, L.1    Andrasik, F.2    Usai, S.3    Bussone, G.4
  • 3
    • 54849435847 scopus 로고    scopus 로고
    • Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain
    • Ranoux D, Attal N, Morain F, Bouhasira D (2008) Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol 2008(64):274-283
    • (2008) Ann Neurol , vol.2008 , Issue.64 , pp. 274-283
    • Ranoux, D.1    Attal, N.2    Morain, F.3    Bouhasira, D.4
  • 4
    • 17244368592 scopus 로고    scopus 로고
    • Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache. A randomized, double blind, placebo controlled trial
    • Mathew N, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C (2005) Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache. A randomized, double blind, placebo controlled trial. Headache 45:293-307
    • (2005) Headache , vol.45 , pp. 293-307
    • Mathew, N.1    Frishberg, B.M.2    Gawel, M.3    Dimitrova, R.4    Gibson, J.5    Turkel, C.6
  • 5
    • 81855194131 scopus 로고    scopus 로고
    • Botulinum toxin type-A in the prophylaxis treatment of medication-overuse headache: A multi center, double blind, randomized, placebo-controlled, parallel group study
    • Sandrini G, Perrotta A, Tassorelli C, Torelli P, Brighina F, Sances G, Nappi G (2011) Botulinum toxin type-A in the prophylaxis treatment of medication-overuse headache: a multi center, double blind, randomized, placebo-controlled, parallel group study. J Head pain 12:427-433
    • (2011) J Head Pain , vol.12 , pp. 427-433
    • Sandrini, G.1    Perrotta, A.2    Tassorelli, C.3    Torelli, P.4    Brighina, F.5    Sances, G.6    Nappi, G.7
  • 6
    • 77957729184 scopus 로고    scopus 로고
    • Method of injection of Onabotulinum toxin A for chronic migraine: A safe, well-tolerated and effective treatment paradigm based on the PREEMPT clinical program
    • Blumenfeld A, Silberstein S, Dodick D, Aurora S, Turkel C, Binder W (2010) Method of injection of Onabotulinum toxin A for chronic migraine: a safe, well-tolerated and effective treatment paradigm based on the PREEMPT clinical program. Headache 50:1406-1418
    • (2010) Headache , vol.50 , pp. 1406-1418
    • Blumenfeld, A.1    Silberstein, S.2    Dodick, D.3    Aurora, S.4    Turkel, C.5    Binder, W.6
  • 7
    • 26444469528 scopus 로고    scopus 로고
    • Review of a proposed mechanisms for the antinociceptive action of botulinum toxin type A
    • Aoki KR (2005) Review of a proposed mechanisms for the antinociceptive action of botulinum toxin type A. Neurotoxicology 26:785-793
    • (2005) Neurotoxicology , vol.26 , pp. 785-793
    • Aoki, K.R.1
  • 8
    • 0042232400 scopus 로고    scopus 로고
    • Evidence for antinociceptive activity of botulinum toxin type A in pain management
    • Aoki KR (2003) Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache 43(suppl):S9-S15
    • (2003) Headache , vol.43 , Issue.SUPPL.
    • Aoki, K.R.1
  • 9
    • 58149157911 scopus 로고    scopus 로고
    • Subcutaneous botulinum toxin type A reduces capsaicin- induced trigeminal pain and vasomotor reactions in human skin
    • Gazerani P, Pedersen NS, Staahl C, Drewes AM, Arendt-Nielsen L (2009) Subcutaneous botulinum toxin type A reduces capsaicin- induced trigeminal pain and vasomotor reactions in human skin. Pain 141:60-69
    • (2009) Pain , vol.141 , pp. 60-69
    • Gazerani, P.1    Pedersen, N.S.2    Staahl, C.3    Drewes, A.M.4    Arendt-Nielsen, L.5
  • 10
    • 1442265540 scopus 로고    scopus 로고
    • The International classification of headache disorders-2nd edition
    • Headache Classification Subcommittee of the International Headache Society
    • Headache Classification Subcommittee of the International Headache Society (2004) The International classification of headache disorders-2nd edition. Cephalalgia 24(suppl 1):1-160
    • (2004) Cephalalgia , vol.24 , Issue.SUPPL. 1 , pp. 1-160


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.